ESC Professional Premium Access

Apixaban for TreatmenT of embolIC stroke of Undetermined Source - ATTICUS randomized trial - explorative analysis of AF burden in the ATTICUS cohort

Congress Presentation

About the speaker

Mrs Timea Keller

University Hospital of Tuebingen, Tuebingen (Germany)
0 follower

7 more presentations in this session

Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study

Speaker: Doctor M. Lehto (Helsinki, FI)

Thumbnail

Trends in newly diagnosed atrial fibrillation and oral anticoagulant use after cardiac surgery: a population-based analysis from Ontario, Canada

Speaker: Mr J. Lee (Toronto, CA)

Thumbnail

Impact of bleeding events on mortality in patients with atrial fibrillation and silent left atrial thrombi: insight from the LAT trial

Speaker: Doctor M. Okada (Osaka, JP)

Thumbnail

Dynamic change in anticoagulation pattern at age 65 years in patients with atrial fibrillation and prior low thromboembolic risk.

Speaker: Mr A. Gonzalez Garcia (Vigo, ES)

Thumbnail

A multiple cut-off diagnostic meta-analysis to identify the atrial high-rate episodes threshold that better relates to thromboembolic events

Speaker: Doctor A. Ballatore (Turin, IT)

Thumbnail

Access the full session

Atrial fibrillation and high-rate episodes: stroke prediction and prevention

Speakers: Mrs T. Keller, Doctor M. Lehto, Mr J. Lee, Doctor M. Okada, Mr A. Gonzalez Garcia...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb